text stringlengths 7 3.2k |
|---|
INTERVERTEBRAL DISC PUNCTURE AND TREATMENT SYSTEM PIQURE DE DISQUE INTERVERTÉBRAL ET SYSTÈME DE TRAITEMENT |
The inventive gastric tube also comprises a second tubular element (108, 208) which is fixed to the first tubular element (101, 201) and provided with means for triggering the swallowing reflex of the patient, the second tubular element (108, 208) being more rigid than the first tubular element (101, 201). La sonde gas... |
A method according to Claim 12 or 13, characterized by mounting elongated elastic elements (15, 17) along the side-edges (11) of said second width-parts (14) of the side-flap webs (10) and thereafter joining the first width-parts (13) of the side-flap webs (10) with the absorbent-unit web (1). Procédé selon la revendic... |
A pharmaceutical composition as claimed in claim 13, wherein the composition comprises per unit dosage a range of from about 0.01 mg to about 1000 mg of L-Val-L-Thr, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. Composition pharmaceutique suivant la revendication 13, ladite c... |
The invention relates to methods for the detection of the amount of a nucleic acid in a sample. La présente invention concerne des procédés qui permettent de détecter la quantité d'acides nucléiques dans un échantillon. |
The method for producing a cross-linked apatite/collagen porous body according to any one of claims 1 to 11, wherein said apatite/collagen composite is produced by freeze-drying a mixture obtained by simultaneously dropping an aqueous solution of phosphoric acid or its salt containing collagen and an aqueous solution o... |
A defined probiotic or composition of anaerobic bacteria effective for controlling or inhibiting Salmonella colonization of fowl. L'invention concerne un probiotique défini ou une composition de bactéries anaérobies efficaces dans l'élimination ou l'inhibition de la colonisation de la volaille par Salmonella. |
An apparatus for applying ionized particles, comprising: an ionized particle emitter (2) for emitting the ionized particles against an object (3) andan electric potential maintainer (4) for maintaining electric potential of the object at a predetermined level such that the ionized particles emitted against the object b... |
The device according to Claim 6 wherein the spray nozzle (20, 220, 320, 120) produces an aerosol generally along a selected aerosol spray path, and the discharge electrode (70, 224, 370, 170) produces ions near an ionization site on the discharge electrode (70, 224, 370, 170) and a corona wind from the discharge electr... |
An ectoparasite-controlling agent according to claim 1, wherein the neonicotinoid compound is 1-(tetrahydrofuran-3-yl)methyl-3-methyl-2-nitroguanidine. Agent de lutte contre les ectoparasites selon la revendication 1, où le composé néonicotinoïde est la 1-(tétrahydrofuran-3-yl)méthyl-3-méthyl-2-nitroguanidine. |
Ultraviolet light source according to Claim 1, characterized in that the lamp body (14) is constructed as a known flat-section emitter, and the profiling of its surface consists of at least one depression (24) extending in its longitudinal direction. Source de lumière UV suivant la revendication 1, caractérisée en ce q... |
Knee prosthesis according to one of Claims 1 to. 4, characterized in that the central rib (30) has a slightly rounded front face (32), and the femoral element (1) has a wall (33) of corresponding shape, this wall (33) being intended to come to rest against this face (32) when the joint is extended. Prothèse de genou se... |
An aqueous hair treatment composition which comprises: (i) from 0.05 to 5% by weight of a non-acidic compound being a hair dye or dye precursor having a molecular weight not over 5000; and (ii) from 0.05 to 30% by weight of an acidic compound chosen from 2-hydroxyhexanoic acid, 2-hydroxyoctanoic acid, 2-hydroxydecanoic... |
An X-ray device comprising an X-ray source (10) and an adjustable diaphragm, or a collimator (14), with a displaceable shutter (14a,14b) which is arranged in front thereof which is driven by a drive (14c) as claimed in any one of the preceding Claims Dispositif à rayons X comprenant une source de rayons X (10) et un di... |
A compound of formula (I) or a pharmaceutically acceptable salt thereof according to any one of claims 1 to 6, or a pharmaceutical composition according to claim 7, for use as a medicament. Composé de formule (I) ou un de ses sels pharmaceutiquement acceptables suivant l'une quelconque des revendications 1 à 6, ou comp... |
This facilitates rotation of the constituent element within the intervertebral disc compartment . Cette disposition facilite la rotation du composant dans le compartiment de disque intervertébral. |
MELANOGENESIS PROMOTER AND MELANOGENESIS PROMOTER COMPOSITION PROMOTEUR DE LA MELANOGENESE ET COMPOSITION DE PROMOTEUR DE LA MELANOGENESE |
Claims for the following Contracting States : AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE: The use of a composition comprising a 15-keto-PGE ester and a pharmaceutically acceptable carrier for the manufacture of a medicament effective for increasing blood pressure. Revendications pour les Etats contractants suivants : A... |
The pair of vectors of claim 12 or claim 13 wherein the locus control region, or component thereof is the β-globin locus control region or component thereof excluding site HS2. Paire de vecteurs selon l'une des revendications 12 ou 13, caractérisée en ce que la région de contrôle locus ou un composant de celle-ci est l... |
The above problem is solved by establishing radical reaction inhibitors containing as the active ingredient cyclic tetrasaccharides or mixtures of cyclic tetrasaccharides with saccharide derivatives thereof, a method for inhibiting the formation of free radicals from unsaturated compounds and radical reactions of the c... |
The bone generating product of claim 13, in which the recombinant compound for generating thrombin is combined with at least a phospholipid selected from the group consisting of phosphatidylserine, derivatives thereof, phosphatidylserine having at least one fatty acid side chain, phosphatidylcholine, derivatives thereo... |
Kit for the manufacture of a dental prosthesis, characterized in that it comprises at least an assembly means formed in a capsule (1) and a counterpiece (2), according to any one of claims 1 to 6, and adapted to be incorporated into said prosthesis and to be fixed on the tooth of a patient. Nécessaire de confection de ... |
The substance PF1191 represented by formula (I), isolated from the culture of a fungus belonging to the genus Eupenicillium by solvent extraction, adsorption column chromatography, gel filtration, etc., and having an inhibitory activity on kanic acid toxicity La présente invention concerne la substance PF1191 représent... |
WEAR RESISTANT TOPICAL COMPOSITIONS HAVING IMPROVED FEEL COMPOSITIONS TOPIQUES RESISTANTES A L'USURE ET PLUS AGREABLES AU TOUCHER |
The dual-lumen catheter of claim 3 wherein said conical tip (15) is molded directly onto the end of said tube (10). Cathéter à canal double selon la revendication 3, dans lequel ledit embout conique (15) est moulé directement au-dessus de l'extrémité dudit tube (10). |
The method of claim 6, wherein the interaction of the test compound with GPR49 results in an inhibition of GPR49 activity. Le procédé selon la revendication 6, dans lequel l'interaction du composé testé avec GPR49 conduit à une inhibition de l'activité de GPR49. |
A sheath (26) is threadedly connected to the fitting and the catheter is slidable and rotatable within the sheath (26). Une gaine (26) est vissée à cet élément annexe et le cathéter peut glisser et tourner dans cette gaine (26). |
Surgical instrument for applying fasteners according to one of claims 1 to 4, characterized in that in the distal region of said shaft (4) said driving means (10) comprises an essentially cylindrical rod (48) which is laterally transposed with respect to the longitudinal axis (L-L) of said shaft (4), the diameter of sa... |
Bone plate in accordance with claim 5, characterized in that the sickle shape has a maximum sickle thickness (14) in the direction of the longitudinal axis of the bone plate (1); and in that the maximum sickle thickness (14) corresponds to at least 8 % of the diameter (17) of the contacting screw head (2a). Plaque d'os... |
The method according to any of claims 1 to 7, characterized in that the DNA molecule is broken, if necessary, by γ irradiation, enzymatic digestion, and/or by mechanical action. Procédé selon l'une des revendications 1 à 7 caractérisé en ce que la molécule d'ADN est cassé si nécessaire par irradiation γ, par digestion ... |
ALUMINIUM TRILACTATE POWDER AND METHOD FOR PREPARATION POUDRE DE TRILACTATE D'ALUMINIUM ET PROCÉDÉ POUR LA PRÉPARER |
The device is an electros?rgical cutting device. Le dispositif est un instrument de coupe électro-chirurgical. |
A system as in claim 12, wherein: said temperature regulating means includes at least a first temperature sensor (75, 76) configured and disposed to sense the temperature of a portion of the fluidizable granular material (14) and to provide signals indicating the temperature of said portion of the fluidizable granular ... |
Compounds in accordance with claim 1 in which X and Y represent >C(CH₃)₂; Z represent -CH₂-CH₂-, R¹ represents pyridyl; R², R⁵ and R⁶ represent hydrogen; and R⁴ represents hydrogen or C₁₋₁₀-alkyl or C₁₋₁₀-alkoxy. Composés selon la revendication 1, dans lesquels X et Y représentent >C(CH₃)₂ ; Z représente -CH₂-CH₂- ; R¹... |
The method includes the steps of (a)determining an initial viewpoint of the virtual endoscope, the initial viewpoint having a first center point and first direction; (b)determining a longest ray from the initial viewpoint to the lumen, the longest ray having a first longest ray direction (step 204); (c)determining a se... |
The stent of claim 1 or 2 wherein the side branch section (15) has a beveled proximal end (23). Stent selon la revendication 1 ou 2, dans lequel ladite section de bifurcation latérale (15) possède une extrémité proximale biseautée (23). |
The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites. Utilisation d'anticorps monoclonaux et de conjugués de ceux-ci comme signaux pour diriger des cellules effecteurs sensibilisées sur des lieux tumoraux. |
The FLD promoter sequences are strongly and independently induced by either methanol as sole carbon source (with ammonium sulfate as nitrogen source) or methylamine as sole nitrogen source (with glucose as carbon source). Les séquences de promoteur FLD sont fortement et indépendamment induites ou bien par le méthanol u... |
A method according to Claim 9, 10 or 11 wherein said tube (18) remains patent at said first and second locations Une méthode selon la revendication 9, 10 ou 11, dans laquelle ledit tube (18) reste ouvert auxdits premier et second emplacements |
The invention relates to insect repellent compositions which are free from N-N-diethyl-m-toluamide (DEET). L'invention concerne des compositions insectifuges qui sont exemptes N-N-diéthyl-m-toluamide (DEET). |
The use of a BU-3608 compound of the formula: wherein R¹, R³, R⁴ and R⁶ have the following meanings: R¹ R³ R⁴ R⁶ -CH₃(D) -NHCH₃ xylosyl =O -CH₃(D) -NH₂ xylosyl =O H -NHCH₃ xylosyl =O H -NH₂ xylosyl =O -CH₃ -NHCH₃ -H =O -CH₃ -NHCH₃ xylosyl =NH for preparing a medicament for inhibiting or treating infection of a suscepti... |
Device according to one of claims 1 to 6, characterised in that the heating device (30) is constructed as a unit with the incoming air riser (21). Dispositif selon l'une des revendications 1 à 6, caractérisé par le fait que le dispositif de chauffage (30) forme une unité avec le conduit d'entrée d'air (21). |
Therapy device according to claim 3, characterised in that the second sensor (103.2) is designed to detect a variable, in particular of the blood pressure, dependent on an organ function or the therapy variable and characterising the physical state of the patient. Appareil de thérapie selon la revendication 3, caractér... |
An electrical unit, as set forth in claim 7 further comprising a ground contact plate (20) which is rigidly connected to the unit casing (1), the contact section (23) is formed as a part of the ground plate (20). Unité électrique selon la revendication 7 comprenant en outre une plaque de contact avec la terre (20) qui ... |
A DNA molecule according to claim 1, from rev -related pM32 (Figures 5A and 6, mutant pM 32 and Example 11 a). Molécule d'ADN selon la revendication 1, issue de pM32 apparenté à rev (Figures SA et 6, mutant pM32 et Fxemple 11a). |
A pharmaceutical composition comprising a therapeutically effective amount of compound of the formula according to claim 1. Composition pharmaceutique comprenant une quantité efficace, du point de vue thérapeutique, d'un composé de formule conforme à la revendication 1. |
A compound according to Claim 1 wherein R 1 and R 3 each are -OH. Composé selon la revendication 1, dans lequel R 1 et R 3 représentent chacun un groupe -OH. |
The composition or method of claim 19, wherein the viral antigen is HIV gp120, HIV p24gag, influenza A haemagglutinin, HCV E1, HCV E2, or herpes simplex virus gD2. Composition ou méthode selon la revendication 19, dans laquelle l'antigène viral est gp120 du HIV, p24gag du HIV, l'hémagglutinine d'influenza A, E1 d'HCV, ... |
In both sites, reducing negative and/or increasing positive charge augmented interaction with iC3/C3b and C4b, supporting a role of ionic forces in the binding reaction. Dans les deux sites, la réduction de la charge négative et/ou l'accroissement de la charge positive ont augmenté l'interaction avec iC3/C3b et C4b, so... |
A system as defined in claim 7 wherein said lighting means comprises an LED (308) at opposite ends of said digital readout. Système tel que défini dans la revendication 7, dans lequel lesdits moyens d' éclairage comprennent une diode électroluminescente (308) aux extrémités opposées dudit affichage numérique. |
Medical laser apparatus Appareil laser médical |
The invention relates to a method for inhibiting alopecia in which cellular quantities of hair keratins are increased. The invention also relates to a system for identifying substances which inhibit alopecia. L'invention concerne un procédé permettant d'inhiber l'alopécie, qui se fonde sur l'augmentation des quantités ... |
A method of acylating a peptide or protein comprising reacting the CoA ester of an oxy- or thio-substituted fatty acid analog compound of Claim 1 with said peptide or protein in the presence of a source of N-myristoyl transferase. Procédé d'acylation d'un peptide ou d'une protéine comprenant le fait de faire réagir l'e... |
GINSENG-CONTAINING AGENT FOR PRODUCING A SENSATION OF SATIETY AND FOR WEIGHT REDUCTION AGENT CONTENANT DU GINSENG DESTINE A LA CREATION D'UN EFFET DE SATIETE ET A LA REDUCTION DE POIDS |
A complex as claimed in Claim 3, characterized in that said radionuclide is Sm-153. Complexe selon la revendication 3, caractérisé en ce que ledit radionuclide est Sm-153. |
MULTIMODAL HIGH STRENGTH DEVICES AND COMPOSITES DISPOSITIFS ET COMPOSITES MULTIMODAUX A RESISTANCE ELEVEE |
An antibody that is directed against a 2F1 polypeptide according to claim 12. Anticorps dirigé contre le polypeptide 2F1 selon la revendication 12. |
A multifunction electrode device according to any of the claims 1 to 8, wherein at least some of the electrode conductors (3c) are asymmetrically arranged on the head section of the electrode device, preferably in a linear configuration on one side of the electrode body (2). Electrode à fonctions multiples selon l'une ... |
The tissue abnormality detection system of Claim 1, further comprising a camera (120) positioned to capture the combined output image onto an image sensor. Le système de détection d'anomalies tissulaires de la Revendication 1, comprenant en outre un dispositif de prise de vues (120) mis en place pour capturer l'image d... |
Cosmetic use of the composition according to any one of Claims 1 to 18, for treating wrinkles and/or fine lines of the skin. Utilisation cosmétique de la composition selon l'une quelconque des revendications 1 à 18 pour le traitement des rides et/ou des ridules de la peau. |
A method as claimed in Claim 13, wherein said human diploid cell line is MRC-5. Procédé selon la revendication 13, dans lequel ladite lignée de cellules diploïdes humaines est MRC-5. |
It is useful for observing or imaging the interior of the eye, the retina, or the choroid. L'invention est utile pour l'observation ou l'imagerie de l'intérieur de l'oeil, de la rétine, ou de la choroïde. |
A method according to Claim 21, in which the microorganism is B. subtilis SMS 118 (pSM228) (ATCC 67322) and the heterologous protein is the mature S3 subunit. Procédé selon la revendication 21, dans lequel le micro-organisme est B. subtilis , SMS 118 (pSM228) (ATCC 67322), et la protéine hétérologue est la sous-unité S... |
The subject invention provides methods and compositions for the treatment of benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases. L'invention concerne des méthodes et des compositions pour le traitement de tumeurs bénignes, des cancers, des néoplasies et/ou tout(e) autre trouble ou malad... |
A method according to claim 28, in which the disulphide bond reducing agent is contained in a phosphate buffered saline. Procédé selon la revendication 28, dans lequel l'agent réducteur des liaisons disulfures est contenu dans une solution salée tamponnée au phosphate. |
A product according to Claim 6, wherein said 3-dehydroshikimic acid or derivative is the acid. Produit suivant la revendication 6, dans lequel ledit acide 3-déshydroshikimique ou un dérivé est l'acide. |
A method of molding an article with a mold having a working surface that defines a predetermined shape, said method comprising: placing a moldable material in a mold according to any one of claims 1 to 4 and forming said moldable material into the desired shape; and thereafter releasing the moldable material from the m... |
A sphincter system according to any one of claims 4 to 6, wherein the fluid pressure required to distend said flexible membrane is higher on fluid connection through said first fluid passage (32) than on fluid connection through said second fluid passage (30). Système de sphincter selon l'une quelconque des revendicati... |
The stent of claim 1 comprising a plurality of stent retaining segments (115). Stent selon la revendication 1 comprenant une multiplicité de segments de retenue de stent (115). |
A composition according to claim 3, comprising sodium carboxymethylcellulose as suspending agent, said composition having a compositional viscosity index of between 3-6. Une composition selon la Revendication 3, comprenant de la carboxyméthylcellulose de sodium en tant qu'agent de suspension, ladite composition présent... |
NERVE CUFF INJECTION MOLD AND METHOD OF MAKING A NERVE CUFF MOULE D'INJECTION DE MANCHON, ET PROCÉDÉ DE FABRICATION DE MANCHON |
The present invention relates to methods of identifying and enriching spermatogonioal stem cells, and compositions thereof. L'invention concerne des méthodes d'identification et d'enrichissement de cellules souches spermatogoniales et des compositions de celles-ci. |
A gastric remaining preparation having a configuration entirely different from that of the conventional ones. L'invention concerne une préparation restant dans l'estomac et dont la configuration est totalement différente des configurations traditionnelles. |
The use according to any of claims 1 or 2, wherein 1- deamino- 8- D-arginine vasopressin (Desmopressin) or a pharmaceutically acceptable salt thereof is further administered as a second dose ranging from 0.3 to 4 µg/kg of body weight by way of an endovenous infusion, 24 hours after surgery. L'utilisation selon l'une qu... |
The treatment preferably comprises the administration of hCG in conjunction with an antiestrogen and/or a Type I Interferon. De préférence, l'administration de hCG se fait conjointement à l'administration d'un anti-oestrogène et/ou d'un interféron de type I. |
The model includes representation of the biological processes related to the synovial tissue and cartilage (item 910). Ledit model comprend une représentation des processus biologiques associés au tissu synovial et au cartilage (910). |
Device according to Claim 6, characterized in that the locking lever (110') is provided with an ejection shoulder (110'') for the outsole element (114). Dispositif selon la revendication 6, caractérisé en ce que le levier d'enclenchement (110') est pourvu d'un épaulement d'éjection (110'') pour l'élément semelle (114). |
Suturing aid according to claim 1 or Claim 2, characterized in that said actuating element (26, 80) is configured as a rod (28, 82), which is arranged to slide along said shaft (12, 72) and is hinged, on the distal end, on said support (46), with the axis (45) of the hinge forming the pivot axis of said support (46). A... |
Antisense compounds, compositions and method are provided for modulating the expression of MADH6. L'invention porte sur des composés antisens, sur des compositions et sur des procédés de modulation de l'expression de MADH6. |
When the side branch is extended and expanded, the connected expansion columns form the wall of the side branch and the framework expands to conform to the shape of a targeted bodily vessel. Lorsque la branche latérale est étendue et dilatée, les colonnes d'expansion reliées forment la paroi de la branche latérale et l... |
The method of Claim 13 wherein the first amplitude of step (f)(1) comprises a non-zero amplitude, and the second amplitude of step (f)(1) comprises a zero amplitude, whereby the presence of an output data pulse having a discernable amplitude at the time in the data frame that is inbetween the biphasic pulses of the dat... |
Method for administering streptolysin 0 for treatment of various conditions including connective tissue disorders, reproductive fibroses and conditions mediated by the CD44 receptor. Cette invention concerne une méthode d'administration de streptolysine 0 pour le traitement de divers états pathologiques, dont les troub... |
A pressure-sensitive adhesive tape comprising a backing and an adhesive layer, the adhesive layer comprising 100 parts of an elastomeric phase and a tackifying phase, the adhesive having a CMTg value of less than about -10°C, the elastomeric phase comprised of from about 78 to 98 parts of a diblock A-B type block copol... |
Some advantages include the minimization of deleterious damage to chromosomal DNA, and adaptation to strains that are amenable to complementation, which substantially facilitates the generation and identification of enzymes with altered properties. Parmi certains avantages, on minimise les dégradations nocives de l'ADN... |
The method according to claim 1 or 2 wherein said composition is stable for from 1 month to 6 months at room temperature and relative humidity of from 70-80%. Procédé selon la revendication 1 ou 2, dans lequel ladite composition est stable pendant une durée de 1 mois à 6 mois à la température ambiante et à une humidité... |
Combination having antilipemic activity substantially free from toxic or side effects due to antilipemic drugs Combinaison ayant une activité hypolipémiante substantiellement dénuée des effets toxiques ou effets secondaires causés par les médicaments à activité hypolipémiante |
Debromohymenialdisine is able to slow the joint deterioration and cartilage degradation associated with the disease. La débromohyménialdisine est capable de ralentir la détérioration des articulations et la dégradation du cartilage associées à la maladie. |
An apparatus (22) for mapping the wall of a chamber of the heart. Appareil (22) destiné à effectuer la cartographie des parois d'une chambre du coeur. |
The dressings may include a flexible backing and carrier. Les pansements peuvent comporter un renfort et un support souples. |
A prosthesis as set forth in Claim 1, wherein the prosthesis is adapted for implantation in a femur and wherein the neck is sized and shaped to inhibit contact with the acetabulum upon implantation in the femur. Prothèse selon la revendication 1, dans laquelle la prothèse est adaptée pour implantation dans un fémur et ... |
An image combining section combines the created ultrasonic image with the created schematic view data to display the ultrasonic image and the schematic view corresponding to the position where an ultrasonic wave is scanned on the same screen of a display section. Une unité de combinaison d'images réalise la combinaison... |
A process for preparing a compound according to any of claims 1-10 comprising the step of: reacting a compound of the formula (II): wherein R is hydrogen atom or a lower alkyl, with a cyclic amine of formula ZH wherein Z is as defined above or an acid addition salt thereof. Un procédé de préparation d'un composé selon ... |
The present invention includes the use of at least one agent which induces endoplasmic reticulum (ER) stress together with at least one agent which gives rise to inhibition of protein disulfide isomerase (PDI) or GRP78 function for the preparation of a medicament, more particularly a medicament for the treatment of can... |
The inductive link comprises at least two coils which are orientated in space in such a way they are located on each side of said physical barrier (3), so that one of the coils, the so-called primary coil (15), is located outside the physical barrier and then forming a part of the primary circuit that generates an elec... |
A dental or medical alginate impression composition is provided. The composition includes an alginate material comprising an alginate in an amount between about 10 and 50 weight percent, a filler material in an amount between about 10 and 90 weight percent, and a binder material in an amount between about 1 and 80 weig... |
A system according to any preceding claim, wherein said viability map is based on electrophysiological data. Dispositif selon l'une quelconque des revendications précédentes, dans lequel ladite carte de viabilité repose sur des données électro-physiologiques. |
In a first step, a sparingly soluble drug is suspended in a liquid containing no pulverizing agent and the suspension is subjected to a high-pressure treatment with a high-pressure homogenizer. Dans une première étape, une médicament soluble est mis en suspension dans un liquide ne contenant aucun agent pulvérisant et ... |
SYSTEM AND METHOD FOR TELESURGERY SYSTÈME ET PROCÉDÉ DE TÉLÉCHIRURGIE |
Use of a composition comprising at least one derivative of interleukin-1, selected from the group consisting of 16G•36D•141S•IL-1α, 36D•141S•IL•1α, Delta (1-14)•36D•141S•IL-1α, Delta (1-15)•IL-1α, Delta (1-15)•36D•141S•IL-1α, (24-153)•IL-1β, (1-82)•IL-1β, and 71S•IL-1β as an effective component, for the manufacture of ... |
In addition, one or more secondary prisms (14) are used to achieve vertical lens shifting so that the desired optical power zone (16,17) of the contact lens (10) is brought before the entrance pupil (26) of the eye at the desired time. En outre, au moins un prisme (14) secondaire permet d'obtenir un décentrement vertic... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.